F10 and atrial fibrillation: Medications that inhibit factor Xa (apixaban, rivaroxaban, and edoxaban) and thrombin (dabigatran) are recommended for patients with AF due to a lower number of strokes, mortality, or intracranial bleeding compared to the therapy of VKA [10].